Peter M Palese

This inventor holds 83 USPTO granted patents and 32 published patent applications and 5 EPO patents, primarily in Influenza Virus Vaccines (CPC class C07K14-005). Top assignees: Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital. Active years: 1992-2025.

USPTO Granted Patents = 83 (Patent Applications = 32)

% Patents Active = 91.6

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 2.9

ph-index = 23

Forward Citations = 2,055(Granted Patents)

Forward Citations (Not Self Cited) = 1,216(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Leoma, NJ (US) (2005)
Leonis, NJ (US) (2005)
Loonta, NJ (US) (2015)
Leonia, NJ (US) (1992 - 2017)
New York, NY (US) (2014 - 2024)

Company Filing History:

71 out of 535

Icahn School of Medicine at Mount Sinai

patents

5 out of 615

Memorial Sloan Kettering Cancer Center

patents

5 out of 280

St. Jude Children's Research Hospital

patents

4. 5 out of 1,214

United States of America, as Represented by the Secretary of Agriculture

Medimmune Vaccines, Inc.

patents

7. 2 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

8. 1 out of 99

Sanford-Burnham Medical Research Institute

patents

9. 1 out of 4

The Mount Sinai Medical Center

University of Kentucky Research Foundation

patents

12. 1 out of 18

Worcester Foundation for Experimental Biology

patents

13. 7 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...

Areas of Expertise:

Influenza Virus

Vaccines

Hemagglutinin Proteins

Chimeric Viruses

Neuraminidase Antibodies

Genetically Engineered Viruses

Monoclonal Antibodies

Negative Strand Viruses

Swine Influenza

Antiviral Compounds

Virus Replication

Newcastle Disease

83 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233123 - Influenza virus hemagglutinin proteins and uses thereof (2025-02-25),

2. 12042534 - Newcastle disease viruses and uses thereof (2024-07-23),

3. 12030928 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2024-07-09),

4. 11865173 - Influenza virus hemagglutinin proteins and uses thereof (2024-01-09),

5. 11266734 - Influenza virus hemagglutinin proteins and uses thereof (2022-03-08),

6. 11254733 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2022-02-22),

7. 10736956 - Influenza virus vaccination regimens (2020-08-11),

8. 10583188 - Influenza virus vaccines and uses thereof (2020-03-10),

9. 10544207 - Antibodies against influenza virus hemagglutinin and uses thereof (2020-01-28),

10. 10543268 - Genetically engineered swine influenza virus and uses thereof (2020-01-28),

11. 10308913 - Chimeric viruses presenting non-native surface proteins and uses thereof (2019-06-04),

12. 10251922 - Newcastle disease viruses and uses thereof (2019-04-09),

13. 10179806 - Influenza virus vaccines and uses thereof (2019-01-15),

14. 10137189 - Influenza virus vaccines and uses thereof (2018-11-27),

15. 10131695 - Influenza virus vaccines and uses thereof (2018-11-20),

Title: The Innovative Journey of Peter M. Palese

Introduction: Peter M. Palese, a distinguished male inventor hailing from Leonia, NJ (US), has made significant contributions to the field of innovations and inventions.

Latest Patents: Peter M. Palese holds several patents in the field of biotechnology and medical research, focusing on novel approaches to combating infectious diseases.

Career Highlights: With a career spanning several decades, Peter M. Palese has been at the forefront of groundbreaking research in virology, particularly in the development of vaccines and antiviral therapies.

Collaborations: Throughout his career, Peter M. Palese has collaborated with leading scientists, research institutions, and pharmaceutical companies to advance the field of virology and infectious disease research.

Conclusion: Peter M. Palese's dedication to innovation and his pioneering work in virology have significantly impacted the scientific community, making him a respected figure in the world of inventions and patents.